Free Trial

Moore Capital Management LP Sells 652,537 Shares of Amrize Ltd $AMRZ

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Moore Capital Management LP sold 652,537 shares of Amrize in the 3rd quarter, cutting its stake by 65.8% to 339,510 shares valued at $16,476,000.
  • Other institutions added large positions — Vanguard raised its stake 41% to 30,094,083 shares (~$1.468B), while Norges Bank and Dodge & Cox established new stakes of roughly $670.9M and $622.1M, respectively.
  • Analyst sentiment is positive with a consensus rating of "Moderate Buy" and a $64.14 price target (several firms raised targets to $70); Amrize beat Q earnings ($0.62 vs $0.59) but missed revenue expectations ($2.84B vs $2.95B).
  • Five stocks to consider instead of Amrize.

Moore Capital Management LP lowered its holdings in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 65.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 339,510 shares of the company's stock after selling 652,537 shares during the period. Moore Capital Management LP owned approximately 0.06% of Amrize worth $16,476,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in Amrize by 41.0% during the 3rd quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company's stock worth $1,468,460,000 after buying an additional 8,743,543 shares during the period. Norges Bank acquired a new stake in Amrize in the second quarter valued at approximately $670,915,000. Dodge & Cox bought a new stake in shares of Amrize during the second quarter valued at approximately $622,085,000. Wellington Management Group LLP increased its holdings in shares of Amrize by 48.8% during the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after acquiring an additional 3,809,133 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Amrize by 4.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,518,018 shares of the company's stock worth $459,242,000 after purchasing an additional 420,728 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on AMRZ shares. JPMorgan Chase & Co. increased their target price on Amrize from $60.00 to $70.00 and gave the stock an "overweight" rating in a report on Thursday, March 5th. Oppenheimer restated an "outperform" rating and set a $70.00 price target (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Bank of America set a $58.00 price objective on shares of Amrize in a report on Monday, January 12th. Berenberg Bank set a $70.00 price objective on shares of Amrize in a research note on Thursday, February 19th. Finally, Vertical Research began coverage on shares of Amrize in a report on Tuesday, November 25th. They set a "hold" rating and a $54.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $64.14.

Get Our Latest Stock Analysis on AMRZ

Amrize Stock Up 1.6%

Shares of NYSE:AMRZ opened at $56.42 on Tuesday. The business's 50 day moving average is $57.93 and its 200 day moving average is $53.73. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $65.94. The stock has a market cap of $31.20 billion and a price-to-earnings ratio of 22.93. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, beating analysts' consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to analysts' expectations of $2.95 billion. Amrize's quarterly revenue was down .4% on a year-over-year basis.

Insider Transactions at Amrize

In other news, CTO Roald Brouwer acquired 2,000 shares of Amrize stock in a transaction on Friday, March 13th. The stock was acquired at an average cost of $54.88 per share, with a total value of $109,760.00. Following the transaction, the chief technology officer owned 18,257 shares of the company's stock, valued at approximately $1,001,944.16. This trade represents a 12.30% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Ian A. Johnston acquired 4,250 shares of the firm's stock in a transaction on Tuesday, March 10th. The stock was purchased at an average price of $58.94 per share, with a total value of $250,495.00. Following the purchase, the chief financial officer owned 25,110 shares in the company, valued at approximately $1,479,983.40. The trade was a 20.37% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have purchased 77,834 shares of company stock worth $4,511,344.

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines